Home › Funds › Two Seas Capital LP › IMVT
Two Seas Capital LP position in IMVT
IMMUNOVANT INC · Health Care
Two Seas Capital LP reported holding 4,612,692 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$155.8M, representing 2.03% of its reported portfolio and ranking #6 among its reported holdings. Two Seas Capital LP has disclosed IMVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How Two Seas Capital LP's IMVT position evolved
Two Seas Capital LP first disclosed a stake in IMVT in Q3 2023 at 86,600 shares (US$3.3M). The position peaked in Q3 2026 at 4,612,692 shares, worth US$155.8M. Across 13 filings, Two Seas Capital LP increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,612,692 shares valued at US$155.8M — an increase of 1,464,187 shares quarter over quarter.. Notable position changes include a 525% increase in Q1 2024 (shares fell 18% over the following quarter), a 123% increase in Q4 2024 (shares fell 31% over the following quarter), a 47% increase in Q3 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 86.60K | $3.32M | New |
| Q4 2023 | 86.60K | $3.65M | Hold |
| Q1 2024 | 541.29K | $17.49M | Add |
| Q2 2024 | 692.41K | $18.28M | Add |
| Q3 2024 | 676.61K | $19.29M | Reduce |
| Q4 2024 | 1.51M | $37.44M | Add |
| Q1 2025 | 1.64M | $28.07M | Add |
| Q2 2025 | 2.25M | $36.04M | Add |
| Q3 2025 | 2.76M | $44.52M | Add |
| Q4 2025 | 2.87M | $72.88M | Add |
| Q1 2026 | 3.20M | $79.54M | Add |
| Q2 2026 | 3.15M | $121.31M | Reduce |
| Q3 2026 | 4.61M | $155.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Deep Track Capital, LP 9.34M sh · $359.91M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.80M sh · $223.67M · Q2 2026
- BAKER BROS. ADVISORS LP 5.44M sh · $209.42M · Q2 2026
- TCG Crossover Management, LLC 4.46M sh · $171.77M · Q2 2026
- RTW INVESTMENTS, LP 3.18M sh · $122.44M · Q2 2026
- ADAR1 Capital Management, LLC 2.33M sh · $89.80M · Q2 2026
- Alpine Global Management, LLC 1.38M sh · $52.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.36M sh · $52.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $46.24M · Q2 2026
- Logos Global Management LP 665.00K sh · $25.62M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 619.10K sh · $23.85M · Q2 2026
More on Two Seas Capital LP
FAQ
How long has Two Seas Capital LP held IMVT?
Two Seas Capital LP has disclosed IMVT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Two Seas Capital LP's current position in IMVT?
As of Q3 2026, Two Seas Capital LP holds 4.61M shares of IMVT (IMMUNOVANT INC), valued at $155.82M, representing 2.03% of its reported portfolio and ranking #6.
Has Two Seas Capital LP been buying or selling IMVT?
In the latest 13F filing (Q3 2026), Two Seas Capital LP increased its position in IMVT. The position peaked in Q3 2026 at 4.61M shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.